| abstract |
The invention relates to compounds of the general formula I, where the groups R, R, X and Y have the meanings indicated in claim 1, which have valuable pharmacological properties, in particular, they are associated with AMP-activated protein kinase and modulate its activity. The compounds are useful for treating and preventing diseases that are affected by this receptor, such as metabolic diseases, in particular type 2 diabetes. |